For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241218:nRSR6236Qa&default-theme=true
RNS Number : 6236Q Chemring Group PLC 18 December 2024
18 December 2024
Chemring Group PLC
PDMR share dealings
Chemring Group PLC ("Chemring" or the "Company") announces that on 17 December
2024 an award of 83,481 deferred ordinary 1p shares in the capital of the
Company previously granted to Michael Ord, a director of the Company, vested.
The deferred share award was originally made in satisfaction of 40% of Mr
Ord's annual bonus payment for the year ended 31 October 2021. 39,434 ordinary
1p shares were subsequently sold by the Company on 18 December 2024 on behalf
of Mr Ord to cover tax and national insurance liabilities arising on vesting.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name
Michael Ord
2 Reason for the notification
a) Position/status Director/PDMR
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Chemring Group PLC
b) LEI 213800U9A54VQJ5P2J41
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Deferred award over ordinary 1p shares
Identification code
GB00B45C9X44
b) Nature of the transaction Vesting of deferred award of shares in partial satisfaction of an annual bonus
payment
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 83,481
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 17 December 2024
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
17 December 2024
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name
Michael Ord
2 Reason for the notification
a) Position/status Director/PDMR
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Chemring Group PLC
b) LEI 213800U9A54VQJ5P2J41
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary 1p shares
Identification code
GB00B45C9X44
b) Nature of the transaction Sale of ordinary 1p shares to meet tax and national insurance liabilities
following vesting of deferred share award
c) Price(s) and volume(s)
Price(s) Volume(s)
314.5p 39,434
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 18 December 2024
f) Place of the transaction XLON - London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
18 December 2024
f)
Place of the transaction
XLON - London Stock Exchange
For further information:
Chemring Group PLC
Sarah Ellard Group Legal Director & Company Secretary +44 (0)7710 553757
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFFVFFLTLIS